
Recipharm to open largest Nordic GLP bioanalysis lab
pharmafile | October 19, 2016 | News story | Manufacturing and Production, Research and Development | Recipharm, Sweden, expansion
Contract development and manufacturing firm Recipharm has announced plans to invest five million Swedish Krona (SEK) in a new GLP-compliant bioanalysis laboratory in its home country of Sweden, the largest of its kind in the Nordic countries.
The 500 square metre laboratory will be added to the firm’s existing development facility in Uppsala in November this year. Planned as a result of increasing customer demand, the lab will upgrade the company’s processing capacity to over 10,000 plasma samples a week.
In addition to building the new facility, the CDMO plans to begin reinforcing its team with new PhD level chemists, with a view to double its 35-strong team in the coming years.
Fredrik Lehmann, general manager at Recipharm Development in Uppsala, said of the investment: ‘This is a strategic investment for Recipharm as there is a real need for more GLP bioanalysis laboratories in the Nordic region. Bioanalysis requires specialist expertise and establishing the necessary capabilities can be a costly investment, proving a barrier to entry for many contract services providers. Having first started out in a collaboration with a subcontractor, we are now delighted to be able to expand our offering in-house to service an unmet need for bioanalysis capabilities.
‘The new laboratory will dramatically increase our capacity, allowing us to continue to grow our European customer base and expand our expert team of chemists.’
Matt Fellows
Related Content

Recipharm offers manufacturing support to vaccine trial from ImmBIO and iiCON
Recipharm, a contract development and manufacturing organisation (CDMO), has successfully manufactured PnuBioVax, a new protein-based …

Recipharm designates Germany site as Centre of Excellence
The multi-product facility recently underwent significant renovations

Strategic alliance announced between Recipharm and Exela
Recipharm and Exela have announced that they have entered into an exclusive strategic alliance. The …






